Healthcare entity

ANVISA

organization

All 1 tracked stories fall under one category: regulation. ANVISA is most often covered alongside Brazil, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. ANVISA appears in 1 tracked Healthcare story from February 22, 2026.

Last mentioned: Feb 22, 2026

Entity pulse

Recent coverage · ANVISA

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about ANVISA

All 1 tracked stories fall under one category: regulation. ANVISA is most often covered alongside Brazil, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. ANVISA appears in 1 tracked Healthcare story from February 22, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering ANVISA. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Implementation Phase

    Expected start of streamlined registration for priority therapeutic categories.

  2. Technical Working Group (Projected)

    First meeting of regulatory experts to define GMP inspection sharing protocols.

  3. Bilateral Briefing

    Government representatives outline the scope of pharmaceutical and medical product alignment.

  4. MoU Exchange

    Official documents exchanged between India and Brazil to initiate regulatory cooperation.

Stories mentioning ANVISA 1

Health Policy Positive

India and Brazil Ink Regulatory Pact to Streamline Pharma and MedTech Trade

India and Brazil have formalized a Memorandum of Understanding (MoU) to harmonize the regulation of pharmaceutical and medical products. This strategic partnership aims to enhance bilateral cooperation, streamline market entry for life sciences companies, and ensure the safety and efficacy of medical goods exchanged between the two major emerging economies.

2 sources

ANVISA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.